NuCoal to keep fires burning on compensation


Published 28-SEP-2015 17:12 P.M.


1 minute read

Hey! Looks like you have stumbled on the section of our website where we have archived articles from our old business model.

In 2019 the original founding team returned to run Next Investors, we changed our business model to only write about stocks we carefully research and are invested in for the long term.

The below articles were written under our previous business model. We have kept these articles online here for your reference.

Our new mission is to build a high performing ASX micro cap investment portfolio and share our research, analysis and investment strategy with our readers.

Click Here to View Latest Articles

ASX-listed NuCoal Resources (ASX:NCR) has come out swinging after the Supreme Court of NSW rejected its appeal of an ICAC finding last year – saying it would continue to seek to leverage “international treaty obligations” to seek compensation.

In July 2013, ICAC found evidence of corruption in the granting of the Mount Penny exploration license to Doyle’s Creek Mining (DCM) in late 2008.

DCM was acquired in 2010 by NCR.

In its judgement, ICAC recommended that the exploration license, now held by NCR, should be revoked with the body recommending the NSW Parliament move to compensate any party affected by the ICAC finding.

However, in January last year the parliament passed legislation revoking the license from NCR without any compensation.

Subsequently, NCR appealed the original ICAC decision to the NSW Supreme Court, arguing that the body did not fully engage with its supplied evidence.

However, Justice Stephen Rothman rejected the case saying that ICAC had fully engaged with the evidence.

Today, NCR told the market that the judgement was not a reflection on its innocence in the case, something which the court agreed with.

However, NCR flagged its intention to pursue the case for compensation further, focusing on compensation for its US investors by leveraging “international treaty obligations.

“NuCoal will continue to press for compensation for its US investors under Australia’s international treaty obligations,” it said in a statement. is seeking further clarification.

General Information Only

S3 Consortium Pty Ltd (S3, ‘we’, ‘us’, ‘our’) (CAR No. 433913) is a corporate authorised representative of LeMessurier Securities Pty Ltd (AFSL No. 296877). The information contained in this article is general information and is for informational purposes only. Any advice is general advice only. Any advice contained in this article does not constitute personal advice and S3 has not taken into consideration your personal objectives, financial situation or needs. Please seek your own independent professional advice before making any financial investment decision. Those persons acting upon information contained in this article do so entirely at their own risk.

Conflicts of Interest Notice

S3 and its associated entities may hold investments in companies featured in its articles, including through being paid in the securities of the companies we provide commentary on. We disclose the securities held in relation to a particular company that we provide commentary on. Refer to our Disclosure Policy for information on our self-imposed trading blackouts, hold conditions and de-risking (sell conditions) which seek to mitigate against any potential conflicts of interest.

Publication Notice and Disclaimer

The information contained in this article is current as at the publication date. At the time of publishing, the information contained in this article is based on sources which are available in the public domain that we consider to be reliable, and our own analysis of those sources. The views of the author may not reflect the views of the AFSL holder. Any decision by you to purchase securities in the companies featured in this article should be done so after you have sought your own independent professional advice regarding this information and made your own inquiries as to the validity of any information in this article.

Any forward-looking statements contained in this article are not guarantees or predictions of future performance, and involve known and unknown risks, uncertainties and other factors, many of which are beyond our control, and which may cause actual results or performance of companies featured to differ materially from those expressed in the statements contained in this article. S3 cannot and does not give any assurance that the results or performance expressed or implied by any forward-looking statements contained in this article will actually occur and readers are cautioned not to put undue reliance on forward-looking statements.

This article may include references to our past investing performance. Past performance is not a reliable indicator of our future investing performance.


Discover Small Cap
Biotech Stocks

Join thousands of other Investors following our stock commentary for Free